Facilitated By

San Antonio Medical Foundation

A Phase 3, Multicenter, Open-Label Extension Study Of Oral Ozanimod For Moderately To Severely Active Crohn's Disease

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Funded by
Research Start Date

The primary objective of this study is to demonstrate the long-term safety and efficacy of ozanimod for the treatment of subjects with moderate to severely active Crohn's disease (CD).

Collaborative Project
Clinical Care
Infectious Disease
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.